.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
McKinsey
UBS
Moodys
Cerilliant
Cipla
Farmers Insurance
Chinese Patent Office
Baxter
Dow

Generated: June 28, 2017

DrugPatentWatch Database Preview

OLUX E Drug Profile

« Back to Dashboard

Which patents cover Olux E, and what generic Olux E alternatives are available?

Olux E is a drug marketed by Mylan Pharms Inc and is included in one NDA. There are four patents protecting this drug.

This drug has forty-six patent family members in twenty countries.

The generic ingredient in OLUX E is clobetasol propionate. There are thirteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

Summary for Tradename: OLUX E

Patents:4
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list40
Clinical Trials: see list3
Patent Applications: see list4,310
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OLUX E at DailyMed

Pharmacology for Tradename: OLUX E

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
OLUX E
clobetasol propionate
AEROSOL, FOAM;TOPICAL022013-001Jan 12, 2007AB2RXYesYes6,730,288► SubscribeY ► Subscribe
Mylan Pharms Inc
OLUX E
clobetasol propionate
AEROSOL, FOAM;TOPICAL022013-001Jan 12, 2007AB2RXYesYes8,460,641► SubscribeY ► Subscribe
Mylan Pharms Inc
OLUX E
clobetasol propionate
AEROSOL, FOAM;TOPICAL022013-001Jan 12, 2007AB2RXYesYes7,029,659► SubscribeY ► Subscribe
Mylan Pharms Inc
OLUX E
clobetasol propionate
AEROSOL, FOAM;TOPICAL022013-001Jan 12, 2007AB2RXYesYes8,962,000► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: OLUX E

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,263,580Vitamin formulation► Subscribe
8,629,128Vitamin formulation► Subscribe
8,449,867Microemulsion and sub-micron emulsion process and compositions► Subscribe
8,298,515Vitamin formulation► Subscribe
9,492,384Microemulsion and sub-micron emulsion process and compositions► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: OLUX E

Country Document Number Estimated Expiration
BrazilPI0514806► Subscribe
New Zealand563560► Subscribe
Israel181632► Subscribe
Japan4972553► Subscribe
China101048136► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
US Department of Justice
Julphar
Farmers Insurance
Colorcon
Cerilliant
Queensland Health
Deloitte
Cipla
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot